Global Dehydroepiandrosterone (DHEA) Market Growth 2025-2031

The global Dehydroepiandrosterone (DHEA) market size is predicted to grow from US$ 49.9 million in 2025 to US$ 76.2 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.

Dehydroepiandrosterone (DHEA), also known as androstenolone, is an endogenous steroid hormone precursor. It is one of the most abundant circulating steroids in humans. DHEA is produced in the adrenal glands, the gonads, and the brain. It functions as a metabolic intermediate in the biosynthesis of the androgen and estrogen sex steroids both in the gonads and in various other tissues. However, DHEA also has a variety of potential biological effects in its own right, binding to an array of nuclear and cell surface receptors, and acting as a neurosteroid and modulator of neurotrophic factor receptors.

Research institutions and pharmaceutical companies are exploring prasterone's potential beyond its current uses, including neuroprotection and metabolic modulation, potentially broadening its market scope. In developed regions like the U.S. and Europe, prasterone is increasingly seen as part of the growing hormone replacement therapy market, driven by an aging population seeking to address not only physical but also sexual and cognitive health declines. As DHEA levels naturally decrease after age 30—particularly rapidly in women—the need for hormonal balance interventions has grown, making prasterone-based therapies more appealing. Additionally, a broader wellness trend focusing on holistic health and quality of life improvements has positioned prasterone as a non-traditional yet scientifically backed option. Significant investments in research by both academia and industry have accelerated the understanding of prasterone's multifaceted benefits, supporting its development as a safer alternative for hormone replacement. Simultaneously, the facial mask market is expanding due to increased skincare awareness among younger generations and the influence of strong skincare cultures in South Korea, Japan, and China. The rise of online sales channels, live streaming, and influencer marketing has amplified brand reach, especially among younger, trend-driven consumers. Men are increasingly embracing skincare, expanding the consumer base, particularly in China. Brands are developing masks tailored to specific skin concerns, incorporating ingredients like sodium hyaluronate and collagen, while also exploring sustainable, eco-friendly materials. Multifunctional masks that combine benefits like anti-aging, hydration, and brightening are becoming popular among busy consumers seeking effective, convenient solutions.

LP Information, Inc. (LPI) ' newest research report, the “Dehydroepiandrosterone (DHEA) Industry Forecast” looks at past sales and reviews total world Dehydroepiandrosterone (DHEA) sales in 2024, providing a comprehensive analysis by region and market sector of projected Dehydroepiandrosterone (DHEA) sales for 2025 through 2031. With Dehydroepiandrosterone (DHEA) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dehydroepiandrosterone (DHEA) industry.

This Insight Report provides a comprehensive analysis of the global Dehydroepiandrosterone (DHEA) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dehydroepiandrosterone (DHEA) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dehydroepiandrosterone (DHEA) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dehydroepiandrosterone (DHEA) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dehydroepiandrosterone (DHEA).

This report presents a comprehensive overview, market shares, and growth opportunities of Dehydroepiandrosterone (DHEA) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
≥ 99％
Others

Segmentation by Application:
Medicine
Dietary Supplements
Skin Care Products
Reagents
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Yicheng Goto Pharmaceuticals Co.,Ltd.
Junye Pharmaceutical Co., Ltd.
Zhejiang Shenzhou Pharmaceutical Co., Ltd.
Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
Jiangsu Jiaerke Pharmaceuticals Group Corp.
Wudang Antai Pharmaceutical Co., Ltd.
Shandong Saito Biotechnology Co., Ltd.
Hubei Dan'ao Pharmaceutical Co., Ltd.
Symbiotec Pharma Lab Pvt. Ltd.
NutriScience Innovations, LLC

Key Questions Addressed in this Report

What is the 10-year outlook for the global Dehydroepiandrosterone (DHEA) market?

What factors are driving Dehydroepiandrosterone (DHEA) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Dehydroepiandrosterone (DHEA) market opportunities vary by end market size?

How does Dehydroepiandrosterone (DHEA) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.